期刊文献+

COPD患者血清hepcidin、sTfR测定在贫血并发症中的应用价值研究 被引量:3

The detection of hepcidin and sTfR in COPD with anemia patients and its clinic significance
下载PDF
导出
摘要 目的检测慢性阻塞性肺疾病(COPD)伴发贫血患者血清中铁调节素(hepcidin)和血清转铁蛋白受体(ser-um transfer-ring receptor,sTfR)的表达变化,探讨其在COPD相关性贫血中的作用。方法收集我院2008年12月~2010年12月收治的COPD患者104例,其中COPD贫血患者24例,COPD非贫血患者80例,另取在本院体检中心健康体检者30例作为对照组。ELISA检测受试者血清hepcidin和sTfR的表达水平。结果 COPD患者中贫血的发病率为23.1%(24/104)。对照(A)组、COPD(B)组和COPD合并贫血(C)组hepcidin的表达水平分别为21.33±5.26、29.46±8.57和41.02±11.34ng/mL,各组间存在显著性差异(F=8.64,P<0.05);A、B和C组中sTfR的表达水平分别为19.21±3.77、27.68±5.72和37.94±8.61nmol/L,各组间亦存在显著性差异(F=7.58,P<0.05);其中C组中hepcidin和sTfR的表达水平均显著高于B组(P<0.05)。轻度、中度和重度组COPD伴发贫血患者hepci-din的表达水平分别为35.42±6.24、42.31±7.44和51.23±12.144ng/mL,各组间存在显著性差异(F=7.64,P<0.05);上述各组中sTfR的表达水平分别为32.27±5.68、40.74±6.46和47.32±9.84nmol/L,各组间亦存在显著性差异(F=7.42,P<0.05)。相关性分析显示血清hepcidin表达水平与患者的血红蛋白水平呈负相关(r=-0.574,P<0.05),血清sTfR表达水平亦与患者的血红蛋白水平呈负相关(r=-0.535,P<0.05),血清hepcidin和sTfR的表达水平呈正相关(r=0.686,P<0.01)。结论 COPD患者hepcidin的升高所导致的机体可利用铁减少可能是COPD相关性贫血的主要成因,Hepcidin有望成为COPD相关性贫血的一个新的治疗靶点,或者是疗效的监控指标。。 Objective To observe the clinical significance of hepcidin and serum transfer-ring receptor(sTfR) in patients with chronic obstructive pulmonary disease(COPD) related anemia.Methods A total of 104 patients with COPD were enrolled in this study.24 COPD patients were diagosed as anemia.30 healthy person were used as a normal control.The expression of hepcidin and sTfR in serum was detected by ELISA analysis.Results The prevalence of anemia COPD was 23.1%(24/104).The level of hepcidin in serum was 21.33±5.26,29.46±8.57,and 41.02±11.34 ng/mL in control(A)group,COPD(B)group and COPD associated anema(C)group,respectively.Significant difference of hepcidin level was found between the three groups(F=8.64,P〈0.05).The level of sTfR in serum was 19.21±3.77,27.68±5.72,and 37.94±8.61 nmol/L in A,B,and C group,respectively.Significant difference of hepcidin level was found between the three groups(F=7.58,P〈0.05).The expression of hepcidin in low,medium,and high anema patients were 35.42±6.24,42.31±7.44,and 51.23±12.144 ng/mL,respectively.Significant difference was found between the three groups(F=7.64,P〈0.05).The expression of sTfR in low,medium,and high anema patients were 32.27±5.68,40.74±6.46,47.32±9.84 nmol/L,respectively.Significant difference was found between the three groups(F=7.42,P〈0.05).The level of hepcidin in serum was negatively related with Hb level(r=-0.574,P〈0.05).The level of sTfR in serum was also negatively related with Hb level(r=-0.535,P〈0.05).The level of hepcidin was positively related with sTfR level(r=0.686,P〈0.05).Conclusion The high-level expression of hepcidin play a key role in the development of COPD-related anemia.Hepcidin may be used as a new target to treat COPD patients with anemia.
出处 《中国实验诊断学》 2012年第9期1603-1606,共4页 Chinese Journal of Laboratory Diagnosis
基金 国家自然科学基金(81100035)
关键词 慢性阻塞性肺疾病 贫血 铁调节素 血清转铁蛋白受体 chronic obstructive pulmonary disease(COPD) anemia hepcidin serum transfer-ring receptor(sTfR)
  • 相关文献

参考文献16

  • 1Agarwal R, Aggarwal AN, Gupta D, et al. Inhaled corticoste- roids vs placebo for preventing COPD exacerbations., a systemat- ic review and metaregression of randomized controlled trials[J]. Chest, 2010, 137(2) :318.
  • 2Short AF, Doyle J, Stern L, et al. Anemia in chronic obstruc- tive pulmonary disease: epidemiology and economic implications [J].Curr MedResOpin, 2008, 24(4):1123.
  • 3Barba R, de Casasola GG, Marco J, et al. Anemia in chronic obstructive pulmonary disease: a readmission prognosis factor [J].Curt MedResOpin, 2012, 28(4) :617.
  • 4Theurl I, Schroll A, Nairz M, et al. Pathways for the regula- tion of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo[J]. Haematologica, 2011, 96 (12) : 1761.
  • 5慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8227
  • 6陆再英,钟南山.内科学(第7版)[M].北京:人民卫生出版社,2008,726-728.
  • 7郭翔廷,魏蓉.Hepcidin与慢性病贫血[J].医学综述,2010,16(1):45-47. 被引量:4
  • 8Young B, Zaritsky J. Hepcidin for clinicians[J]. Clin J Am Soc Nephrol, 2009, 4(8):1384.
  • 9Pietrangelo A. Hepcidin in human iron disorders: therapeutic implications[J]. J Hepatol, 2011, 54(1) :173.
  • 10Ganz T, Nemeth E. Hepcidin and disorders oaf iron metabolism [J]. AnnuRevMed, 2011, 62(2) :347.

二级参考文献41

共引文献8313

同被引文献33

  • 1付丽娟,段相林,钱忠明,常彦忠.铁代谢与铁调素hepcidin[J].生理科学进展,2005,36(3):233-236. 被引量:22
  • 2陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 3Panetta NL, Krachman S, Chatila WM. Chronic obstructive pulmonary dis- ease and its comorbidities[ J. Panminerva Med ,2009 ,51 (2) :115-23.
  • 4中华医学会呼吸病学分会慢性阻塞性肺疾病组.慢性阻塞性肺疾病防治指南(2007年修订版)(J].中华结核和呼吸杂志,2007,300):8-17.
  • 5Yohannes AM, Ershler WB. Anemia in COPD : a systematic review of the prevalence, quality of life, and mortality [ J , Respir Care, 2011 , 56 ( 5 ) : 644 -52.
  • 6Weiss G, Goodnough LT. Anemia of chronic disease[ J. N Engl J Med, 2005 ,352 (10) :1011-23.
  • 7Roy CN, Weinstein DA, Andrews NC. 2002 E. Mead Johnson Award for Research in Pediatrics Lecture : the molecular biology of the anemia of chronic disease: a hypothesis [ J ]Pediatr Res ,2003 ,53 (3) :507 -12.
  • 8陈红,邓佳,冯玉麟.慢性阻塞性肺疾病相关性贫血[J].中国呼吸与危重监护杂志,2009,8(6):606-608. 被引量:10
  • 9王凤丹,周道斌.慢性病贫血铁调节蛋白研究新进展[J].中国实验血液学杂志,2009,17(6):1616-1618. 被引量:3
  • 10郭翔廷,魏蓉.Hepcidin与慢性病贫血[J].医学综述,2010,16(1):45-47. 被引量:4

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部